Marcelo Bragatte

Ms. Marcelo Bragatte

UFRGS
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
LLLuciano Werle Lunardi
Luciano Werle Lunardi
Marcelo BragatteMarcelo Bragatte
Marcelo Bragatte
GVGustavo Fioravanti Vieira
Gustavo Fioravanti Vieira
The interaction of HIV-1, human leukocyte antigen (HLA), and elite controllers (EC) compose a still intricate triad. Elite controllers maintain a very low viral load and a normal CD4 count, even without antiretrovirals. There is a lot of diversity in HIV subtypes and HLA alleles. The most common subtype in each country varies depending on its localization and epidemiological history. As we know EC appears to maintain an effective CD8 response against HIV. In this phenomenon, some alleles of HLAs are associated with a slow progression of HIV infection, others with a rapid progression. This relationship also depends on the virus subtype. Epitopes of Gag protein-restricted by HLA-B*57 generated a considerable immune response in EC. However, some mutations allow HIV to escape the CD8 response, while others do not. HLA protective alleles, like HLA-B*27, HLA-B*57 and HLA-B*58:01, that are common in Caucasians infected with HIV-1 Clade B, do not show the same protection in sub-Saharan Africans infected by HIV-1 Clade C. Endogenous pathway of antigen processing and presentation is used to present intracellular synthesized cellular peptides as well as viral protein fragments via the MHC class I molecule to the cytotoxic T-lymphocytes (CTLs). Some epitopes are immunodominant, which means that they drive the immune reaction to some virus. Mutation on an anchor residue of epitope necessary for binding on MHC class I is used by HIV to escape the immune system. Mutations inside or flanking an epitope may lead to T cell lack of recognition and CTL escape. Studying how immunodominance at epitopes drives the EC in a geographically dependent way with genetics and immunological elements orchestrating it may help future research on vaccines or immunotherapy for HIV.

22 August 2020 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
LBLuciana Rodrigues Carvalho Barros
Luciana Rodrigues Carvalho Barros
PSPaulo Thiago Souza-Santos
Paulo Thiago Souza-Santos
MPMarco Antonio Marques Pretti
Marco Antonio Marques Pretti
GVGustavo Fioravanti Vieira
Gustavo Fioravanti Vieira
Marcelo BragatteMarcelo Bragatte
Marcelo Bragatte
MBMartin Bonamino
Martin Bonamino

28 October 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
MMMarcus Mendes
Marcus Mendes
Marcelo BragatteMarcelo Bragatte
Marcelo Bragatte
PVPriscila Vianna
Priscila Vianna
MFMartiela Vaz de Freitas
Martiela Vaz de Freitas
IPIna Pöhner
Ina Pöhner
GVGustavo Fioravanti Vieira
Gustavo Fioravanti Vieira
The therapeutic targeting of the immune system, for example in vaccinology and cancer treatment, is a challenging task and the subject of active research. Several in silico tools used for predicting immunogenicity are based on the analysis of peptide sequences binding to the Major Histocompatibility Complex (pMHC). However, few of these bioinformatics tools take into account the pMHC three-dimensional structure. Here, we describe a new bioinformatics tool, MatchTope, developed for predicting peptide similarity, which can trigger cross-reactivity events, by computing and analyzing the electrostatic potentials of pMHC complexes. We validated MatchTope by using previously published data from in vitro assays. We thereby demonstrate the strength of MatchTope for similarity prediction between targets derived from several pathogens as well as for indicating possible cross responses between self and tumor peptides. Our results suggest that MatchTope can enhance and speed up future studies in the fields of vaccinology and cancer immunotherapy.

28 February 2019 in Human Mutation
Verified
Journal Article
Closed access
PDF file
MMMariana R. Meireles
Mariana R. Meireles
Marcelo BragatteMarcelo Bragatte
Marcelo Bragatte
EBEliane Bandinelli
Eliane Bandinelli
FSFrancisco M. Salzano
Francisco M. Salzano
GVGustavo Fioravanti Vieira
Gustavo Fioravanti Vieira

22 November 2019 in Cells
Verified
Journal Article
Open access
PDF file
PVPriscila Vianna
Priscila Vianna
MMMarcus Mendes
Marcus Mendes
Marcelo BragatteMarcelo Bragatte
Marcelo Bragatte
PFPriscila S. Ferreira
Priscila S. Ferreira
FSFrancisco M. Salzano
Francisco M. Salzano
GVGustavo Fioravanti Vieira
Gustavo Fioravanti Vieira
The search for epitopes that will effectively trigger an immune response remains the “El Dorado” for immunologists. The development of promising immunotherapeutic approaches requires the appropriate targets to elicit a proper immune response. Considering the high degree of HLA/TCR diversity, as well as the heterogeneity of viral and tumor proteins, this number will invariably be higher than ideal to test. It is known that the recognition of a peptide-MHC (pMHC) by the T-cell receptor is performed entirely in a structural fashion, where the atomic interactions of both structures, pMHC and TCR, dictate the fate of the process. However, epitopes with a similar composition of amino acids can produce dissimilar surfaces. Conversely, sequences with no conspicuous similarities can exhibit similar TCR interaction surfaces. In the last decade, our group developed a database and in silico structural methods to extract molecular fingerprints that trigger T-cell immune responses, mainly referring to physicochemical similarities, which could explain the immunogenic differences presented by different pMHC-I complexes. Here, we propose an immunoinformatic approach that considers a structural level of information, combined with an experimental technology that simulates the presentation of epitopes for a T cell, to improve vaccine production and immunotherapy efficacy.

1 January 2024 in Revista Brasileira de Epidemiologia
Verified
Journal Article
Open access
PDF file
ISIsaac Negretto Schrarstzhaupt
Isaac Negretto Schrarstzhaupt
Marcelo BragatteMarcelo Bragatte
Marcelo Bragatte
LKLeticia Kawano-Dourado
Leticia Kawano-Dourado
LOLeonardo Rovatti de Oliveira
Leonardo Rovatti de Oliveira
GVGustavo Fioravanti Vieira
Gustavo Fioravanti Vieira
MFMellanie Fontes-Dutra
Mellanie Fontes-Dutra
Objective: Describe the development, implementation, and utilization of dashboards for epidemiological analysis through open data research during the COVID-19 pandemic. Methods: The dashboards were designed to analyze COVID-19 related public data from various sources, including official government data and social media, at world level. Data processing and cleaning techniques were used to join datasets. We calculated Spearman correlation coefficient between the COVID-like symptoms data of the University of Maryland and Facebook Health research, called COVID Trends and Impacts Survey (CTIS) and the official data of notified COVID-19 cases by the Brazilian Health Ministry. Results: The dashboards were successful in predicting the onset of new waves of COVID-19 in Brazil. The data analysis revealed a correlation between the CTIS and the official number of cases the country. This article shows the potential of interactive dashboards as a decision-making tool in the context of public health emergencies, as it was used by the official communication of the Rio Grande do Sul state government. Conclusion: The use of dashboards for predicting the spread of COVID-19 in Brazil was a useful tool for decision-making. To anticipate waves of the disease gives time so that these decisions can be potentially more assertive. This drafts the need of more interdisciplinary actions of this nature, with visualization tools on epidemiologic research.